Articles tagged with: Memory
News»

Results from a recent study indicate that many myeloma patients are likely to suffer impaired cognitive function after their initial multiple myeloma therapy, and stem cell transplantation often causes further impairment.
Nearly half of the patients in the study had cognitive impairment, often referred to as ‘chemo brain,’ after receiving initial anti-myeloma therapy. Half of the patients experienced further impairment of cognitive function at one month and again at three months following autologous (own) stem cell transplantation.
The study authors explain that the most common signs of cognitive impairment were problems with …